BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10892430)

  • 1. Human immunodeficiency virus types 1 and 2 infection in some rural areas of Nigeria.
    Odaibo GN; Olaleyé OD; Tomori O
    Rom J Virol; 1998; 49(1-4):89-95. PubMed ID: 10892430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of HIV among male prisoners in Lagos State, Nigeria.
    Dada MO; Akanmu AS; Esan OA
    Niger Postgrad Med J; 2006 Mar; 13(1):6-9. PubMed ID: 16633370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection with human immunodeficiency viruses and human T-cell lymphotropic viruses in the same individuals in Nigeria.
    Olaleye OD; Ekweozor CC
    Rev Roum Virol; 1993; 44(3-4):233-6. PubMed ID: 7826875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of HIV-1 infection in a rural medical clinic in Haiti.
    Ollé-Goig JE; Rodés A; Barrera JM
    J Trop Med Hyg; 1993 Aug; 96(4):222-4. PubMed ID: 8345541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low prevalence of human T lymphotropic virus type I in !Kung San in Bushmanland, Namibia.
    Steele AD; Bos P; Joubert JJ; Evans AC; Joseph S; Tucker L; Aspinall S; Lecatsas G
    Am J Trop Med Hyg; 1994 Oct; 51(4):460-5. PubMed ID: 7943573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of HIV-1 and HIV-2 antibodies in rural areas of Benin].
    Chippaux JP; Mouillot L; Castel J; Bouchet B; Massougbodji A; Zohoun T; Zohoun I
    Bull Soc Pathol Exot; 1990; 83(4):437-45. PubMed ID: 2285997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV sero-prevalence among children diagnosed with TB in Nigeria.
    Daniel OJ; Ogunfowora OB; Oladapo OT
    Trop Doct; 2007 Oct; 37(4):268-9. PubMed ID: 17988511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of human immunodeficiency virus (HIV) antibodies in tuberculosis patients in Lagos, Nigeria.
    Idigbe EO; Nasidi A; Anyiwo CE; Onubogu C; Alabi S; Okoye R; Ugwu O; John EK
    J Trop Med Hyg; 1994 Apr; 97(2):91-7. PubMed ID: 8170009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type-1 (HIV-1) and the associated clinical features among sero-positive Nigerian subjects.
    Elemuwa CO; Uche LN; Ukwandu NC; Nmorsi OP; Anyanwu LC
    J Commun Dis; 2007 Mar; 39(1):13-9. PubMed ID: 18338711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV seroprevalence in emergency department patients: Lagos University Teaching Hospital, Lagos, 1999.
    Esan OA; Akanmu AS; Akinsete I
    Niger Postgrad Med J; 2003 Jun; 10(2):71-5. PubMed ID: 14567038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited evidence of human immunodeficiency virus type 2 (HIV-2) infection in sera from blood donors showing positive ELISA but negative or indeterminate western blot reactivity for HIV-1 infection.
    Chattopadhya D; Kumari S; Verghese T
    J Commun Dis; 1991 Sep; 23(3):206-7. PubMed ID: 1812169
    [No Abstract]   [Full Text] [Related]  

  • 12. Seroprevalence of human immunodeficiency virus-2 in and around Amritsar.
    Arora U; Jindal N; Chopra S
    Indian J Pathol Microbiol; 2007 Oct; 50(4):926-7. PubMed ID: 18306608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of human immunodeficiency virus among blood donors in a rural Ethiopian hospital.
    Ramos JM; Reyes F; Tesfamariam A
    Trop Doct; 2008 Jul; 38(3):182-3. PubMed ID: 18628556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency seropositivity among mother-child pairs in South West Nigeria: a community-based survey.
    Omotade O; Olaleye DO; Saliu L; Odaibo NG; Adeyemo AA
    West Afr J Med; 2001; 20(4):232-6. PubMed ID: 11885878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Could saliva be used to detect HIV seroconversion?].
    Sangaré KA; Koffi AR; Coulibaly IM; Doulourou C
    Sante; 1997; 7(5):303-7. PubMed ID: 9480036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sero-prevalence of HIV antibodies in tuberculosis patients in Ile-Ife, Nigeria.
    Onipede AO; Idigbe O; Ako-Nai AK; Omojola O; Oyelese AO; Aboderin AO; Akinosho ; Komolafe AO; Wemambu SN
    East Afr Med J; 1999 Mar; 76(3):127-32. PubMed ID: 10442110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-I and HIV-I antibody frequency in thalassemics and drug addicts in southeast Sicily.
    Gulisano G; Ciccia M; Ienna M; Cipolla A; Mauro L
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):531-4. PubMed ID: 1670058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection in Egypt: a two and a half year surveillance.
    Constantine NT; Sheba MF; Watts DM; Farid Z; Kamal M
    J Trop Med Hyg; 1990 Apr; 93(2):146-50. PubMed ID: 2325196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing risk of transfusion-associated AIDS as the pandemic spreads: experience in Maiduguri, Nigeria.
    Harry TO; Moses AE; Ola TO; Obi SO; Bajani MD
    J Trop Med Hyg; 1993 Apr; 96(2):131-3. PubMed ID: 8459487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of testing and potential impact on HIV prevention in Nigeria.
    Odaibo GN; Donbraye E; Adewumi MO; Bakarey AS; Ibeh MA; Olaleye DO
    Afr J Med Med Sci; 2006 Dec; 35 Suppl():131-5. PubMed ID: 18050787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.